img

Biochips Market Status and Trend Analysis 2017-2034 (COVID-19 Version)


Published on: 2024-01-04 | No of Pages : 91 | Industry : Life & Medical

Publisher : 9 | Format : PDF

Biochips Market Status and Trend Analysis 2017-2034 (COVID-19 Version)

Summary

Further key aspects of the report indicate that
Chapter 1Research ScopeProduct Definition, Type, End-Use & Methodology
Chapter 2Global Industry Summary
Chapter 3Market Dynamics
Chapter 4Global Market Segmentation by region, type and End-Use
Chapter 5North America Market Segmentation by region, type and End-Use
Chapter 6Europe Market Segmentation by region, type and End-Use
Chapter 7Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8South America Market Segmentation by region, type and End-Use
Chapter 9Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10Market Competition by Companies
Chapter 11Market forecast and environment forecast.
Chapter 12Industry Summary.

The global Biochips market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.


Based on the type of product

the global Biochips market segmented into
DNA chips 
Lab-on-a-chip 
Protein chips 

Based on the end-use

the global Biochips market classified into
Biotechnology 
Genomics and proteomics 
Drug screening and development 
Molecular diagnostics 
Microfluidic technologie 
Microarray and biosensors

Based on geography

the global Biochips market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are


Affymetric Inc 
Illumina Inc 
GE Healthcare Ltd 
Agilent Technologies Inc 
Roche NimbleGen 
Life Technologies Corporation 
EMD Millipore 
Bio-Rad Laboratories Inc 
Abbott Laboratories 
Fluidigm Corporation

Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOCHIPS INDUSTRY
2.1 Summary about Biochips Industry
2.2 Biochips Market Trends
2.2.1 Biochips Production & Consumption Trends
2.2.2 Biochips Demand Structure Trends
2.3 Biochips Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 DNA chips 
4.2.2 Lab-on-a-chip 
4.2.3 Protein chips 
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Biotechnology 
4.3.2 Genomics and proteomics 
4.3.3 Drug screening and development 
4.3.4 Molecular diagnostics 
4.3.5 Microfluidic technologie 
4.3.6 Microarray and biosensors
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 DNA chips 
5.2.2 Lab-on-a-chip 
5.2.3 Protein chips 
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Biotechnology 
5.3.2 Genomics and proteomics 
5.3.3 Drug screening and development 
5.3.4 Molecular diagnostics 
5.3.5 Microfluidic technologie 
5.3.6 Microarray and biosensors
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 DNA chips 
6.2.2 Lab-on-a-chip 
6.2.3 Protein chips 
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Biotechnology 
6.3.2 Genomics and proteomics 
6.3.3 Drug screening and development 
6.3.4 Molecular diagnostics 
6.3.5 Microfluidic technologie 
6.3.6 Microarray and biosensors
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 DNA chips 
7.2.2 Lab-on-a-chip 
7.2.3 Protein chips 
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Biotechnology 
7.3.2 Genomics and proteomics 
7.3.3 Drug screening and development 
7.3.4 Molecular diagnostics 
7.3.5 Microfluidic technologie 
7.3.6 Microarray and biosensors
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 DNA chips 
8.2.2 Lab-on-a-chip 
8.2.3 Protein chips 
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Biotechnology 
8.3.2 Genomics and proteomics 
8.3.3 Drug screening and development 
8.3.4 Molecular diagnostics 
8.3.5 Microfluidic technologie 
8.3.6 Microarray and biosensors
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 DNA chips 
9.2.2 Lab-on-a-chip 
9.2.3 Protein chips 
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Biotechnology 
9.3.2 Genomics and proteomics 
9.3.3 Drug screening and development 
9.3.4 Molecular diagnostics 
9.3.5 Microfluidic technologie 
9.3.6 Microarray and biosensors
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Affymetric Inc 
10.1.2 Illumina Inc 
10.1.3 GE Healthcare Ltd 
10.1.4 Agilent Technologies Inc 
10.1.5 Roche NimbleGen 
10.1.6 Life Technologies Corporation 
10.1.7 EMD Millipore 
10.1.8 Bio-Rad Laboratories Inc 
10.1.9 Abbott Laboratories 
10.1.10 Fluidigm Corporation
10.2 Biochips Sales Date of Major Players (2017-2020e)
10.2.1 Affymetric Inc 
10.2.2 Illumina Inc 
10.2.3 GE Healthcare Ltd 
10.2.4 Agilent Technologies Inc 
10.2.5 Roche NimbleGen 
10.2.6 Life Technologies Corporation 
10.2.7 EMD Millipore 
10.2.8 Bio-Rad Laboratories Inc 
10.2.9 Abbott Laboratories 
10.2.10 Fluidigm Corporation
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biochips Product Type Overview
Table Biochips Product Type Market Share List
Table Biochips Product Type of Major Players
Table Brief Introduction of Affymetric Inc 
Table Brief Introduction of Illumina Inc 
Table Brief Introduction of GE Healthcare Ltd 
Table Brief Introduction of Agilent Technologies Inc 
Table Brief Introduction of Roche NimbleGen 
Table Brief Introduction of Life Technologies Corporation 
Table Brief Introduction of EMD Millipore 
Table Brief Introduction of Bio-Rad Laboratories Inc 
Table Brief Introduction of Abbott Laboratories 
Table Brief Introduction of Fluidigm Corporation
Table Products & Services of Affymetric Inc 
Table Products & Services of Illumina Inc 
Table Products & Services of GE Healthcare Ltd 
Table Products & Services of Agilent Technologies Inc 
Table Products & Services of Roche NimbleGen 
Table Products & Services of Life Technologies Corporation 
Table Products & Services of EMD Millipore 
Table Products & Services of Bio-Rad Laboratories Inc 
Table Products & Services of Abbott Laboratories 
Table Products & Services of Fluidigm Corporation
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biochips Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biochips Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biochips Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biochips Market Forecast (Million USD) Share by Demand 2021f-2026f